−1.02USD
−17.57 MUSD
71.52 MUSD
16.03 M
About OptimizeRx Corporation
Sector
Industry
CEO
William J. Febbo
Website
Headquarters
Waltham
Employees (FY)
136
Founded
1985
ISIN
US68401U2042
FIGI
BBG000HKQH91
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Waltham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OPRX is 9.24 USD — it has decreased by 1.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange OptimizeRx Corporation stocks are traded under the ticker OPRX.
OptimizeRx Corporation is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
OPRX stock is 3.58% volatile and has beta coefficient of 2.69. Check out the list of the most volatile stocks — is OptimizeRx Corporation there?
One year price forecast for OptimizeRx Corporation has a max estimate of 20.00 USD and a min estimate of 13.00 USD.
OPRX earnings for the last quarter are 0.09 USD per share, whereas the estimation was 0.03 USD resulting in a 260.00% surprise. The estimated earnings for the next quarter are 0.38 USD per share. See more details about OptimizeRx Corporation earnings.
OptimizeRx Corporation revenue for the last quarter amounts to 16.33 M USD despite the estimated figure of 15.14 M USD. In the next quarter revenue is expected to reach 27.92 M USD.
Yes, you can track OptimizeRx Corporation financials in yearly and quarterly reports right on TradingView.
OPRX stock has fallen by 15.62% compared to the previous week, the month change is a 27.07% fall, over the last year OptimizeRx Corporation has showed a 36.71% decrease.
OPRX net income for the last quarter is −4.14 M USD, while the quarter before that showed −2.87 M USD of net income which accounts for −44.54% change. Track more OptimizeRx Corporation financial stats to get the full picture.
Today OptimizeRx Corporation has the market capitalization of 170.02 M, it has decreased by 0.98% over the last week.
No, OPRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OPRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OptimizeRx Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 136.00 employees. See our rating of the largest employees — is OptimizeRx Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OptimizeRx Corporation technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OptimizeRx Corporation stock shows the sell signal. See more of OptimizeRx Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OptimizeRx Corporation future price: according to them, OPRX price has a max estimate of 20.00 USD and a min estimate of 13.00 USD. Read a more detailed OptimizeRx Corporation forecast: see what analysts think of OptimizeRx Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OptimizeRx Corporation EBITDA is −10.82 M USD, and current EBITDA margin is −15.13%. See more stats in OptimizeRx Corporation financial statements.